Showing results (721-730 of 942) with videos related to
Sort By:
Pageof 95
Diabetes Care|August 9, 2023
Risk Assessment of Kidney Disease Progression and Efficacy of SGLT2 Inhibition in Patients With Type 2 DiabetesFilipe A Moura, David D Berg, Andrea Bellavia, et al.American Heart Journal|September 26, 2006
Association between thrombolysis in myocardial infarction myocardial perfusion grade, biomarkers, and clinical outcomes among patients with moderate- to high-risk acute coronary syndromes: observations from the randomized trial to evaluate the relative PROTECTion against post-PCI microvascular dysfunction and post-PCI ischemia among antiplatelet and antithrombotic agents-Thrombolysis In Myocardial Infarction 30 (PROTECT-TIMI 30)C Michael Gibson, Ajay J Kirtane, David A Morrow, et al.American Heart Journal|June 23, 2007
Global outcomes of ST-elevation myocardial infarction: comparisons of the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction study 25 (ExTRACT-TIMI 25) registry and trialBenjamin A Steinberg, Nazanin Moghbeli, Jacqueline Buros, et al.JACC. Advances|June 28, 2024
Effects of Sacubitril/Valsartan vs Valsartan in De Novo vs Acute on Chronic HFpEF and HFmrEFEvan M Murray, Derek Cyr, Marat Fudim, et al.Journal of the American College of Cardiology|April 6, 2004
Association of a pulsatile blood flow pattern on coronary arteriography and short-term clinical outcomes in acute myocardial infarctionC Michael Gibson, Juhana Karha, Sabina A Murphy, et al.JAMA|December 26, 2001
Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction: results from a randomized trialD A Morrow, C P Cannon, N Rifai, et al.American Heart Journal|December 18, 2007
Myeloid-related protein 8/14 and the risk of cardiovascular death or myocardial infarction after an acute coronary syndrome in the Pravastatin or Atorvastatin Evaluation and Infection Therapy: Thrombolysis in Myocardial Infarction (PROVE IT-TIMI 22) trialDavid A Morrow, Yunmei Wang, Kevin Croce, et al.Advances in Therapy|June 11, 2024
De-escalation of Disease-Modifying Therapy for People with Multiple Sclerosis Due to Safety Considerations: Characterizing 1-Year Outcomes in 25 People Who Switched from Ocrelizumab to Diroximel FumarateMark Gudesblatt, Barbara Bumstead, Marijean Buhse, et al.The American Journal of Emergency Medicine|July 26, 2023
Frequency, compliance, and yield of cardiac testing after high-sensitivity troponin accelerated diagnostic protocol implementationChristopher W Baugh, Ron Blankstein, Ishani Ganguli, et al.Multiple Sclerosis and Related Disorders|May 27, 2015
Achieving patient engagement in multiple sclerosis: A perspective from the multiple sclerosis in the 21st Century Steering GroupPeter Rieckmann, Alexey Boyko, Diego Centonze, et al.Pageof 95